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Abstract
Purpose: The aim of this study was to evaluate the feasibility of renal oxygenation assessment using blood oxygen 
level-dependent (BOLD) magnetic resonance imaging (MRI) in the early period after kidney transplantation and to 
estimate its prognostic value for delayed graft function.
Material and methods: Examinations were performed in 50 subjects: 40 patients within a week after the kidney trans-
plantation and 10 healthy controls, using T2*-weighted sequence. Measurements in transplant patients were corre-
lated to basic laboratory parameters in the early period after transplantation and at follow-up.
Results: Examinations of seven patients (18%) were rejected due to their poor technical quality. Mean R2* values 
in transplant recipients were lower than in controls (11.6 vs. 15.9 Hz; p = 0.0001). An R2* value of 0.28 Hz was 
calculated as the minimal detectable change. There was no relation between R2* values and laboratory parameters. 
However, patients eGFR ≥ 40 ml/min/1.73 m2 presented higher R2* values than recipients eGFR < 40 ml/min/1.73 m2  
(12.0 vs. 11.1 Hz; p = 0.0189). In ROC analysis R2* of ≤ 11.7 predicted an early reduced graft function with 0.82 sen-
sitivity and 56% specificity (AUC = 0.708; p = 0.024) but was not useful for delayed graft function prediction (p > 0.7).
Conclusions: Evaluation of renal graft oxygenation using BOLD MRI is technically challenging in the early period 
after transplantation. An R2* value of 0.28 Hz may in practice be considered as the minimal detectable change. The 
delayed graft function seems not to be dependent on early oxygenation values. Further, large-scale studies are nec-
essary to confirm the latter observation.
Key words: renal graft oxygenation, BOLD MRI, blood oxygen level dependent (BOLD) magnetic resonance, kidney 
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Introduction
Renal transplantation is the most effective therapeutic 
method for end-stage chronic kidney disease (CKD). Un-
fortunately, there are currently no good markers of early 
allograft injury, and a kidney biopsy is often required for 
diagnostic purposes [1]. However, the clinical utility of 
this approach is not clear. Biopsy also carries the risk of 
significant graft injury, and it cannot be performed in pa-
tients who take anticoagulants [2]. Therefore, current best 
practice involves vigilant monitoring of simple markers 
of allograft function, such as serum creatinine and pro-
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teinuria. More complex and expensive approaches, such 
as monitoring of serum anti-HLA antibodies, remain un-
proven [3]. Thus, a non-invasive, fast, and specific tool 
that would detect acute allograft parenchymal pathologies 
is desirable [2].
Magnetic resonance imaging (MRI) could become 
a one-stop shop modality for transplanted kidney eval-
uation, as it is an established method for renal graft 
morphology and vasculature assessment [4,5]. Recently, 
several MRI techniques that evaluate renal graft function 
have been introduced [6-8]. For instance, blood oxygen 
level-dependent (BOLD) imaging can depict blood flow 
and parenchymal oxygen bioavailability [9,10], which may 
be related to renal graft metabolism and thus can become 
a surrogate biomarker of graft survival.
BOLD MRI can be used for non-invasive estimation 
of renal parenchymal oxygen concentration. BOLD MRI 
is based on the paramagnetic effect of deoxyhaemoglo-
bin for indirect depiction of renal oxygenation, whereby 
an increased oxygen consumption results in an increased 
deoxygenated haemoglobin concentration. This leads to 
decreased T2* relaxation times on renal parenchyma im-
ages, which can be measured as the rate of spin dephas-
ing (R2* = 1/T2*) [9]. Thus, R2* may be considered as 
an indicator of renal metabolism [10]. However, factors 
other than oxygenation, such as perfusion, haematocrit, 
or microstructure, can influence the deoxyhaemoglobin 
concentration and thus the R2* values. 
It was shown that renal cortical oxygenation, meas-
ured with BOLD imaging, was reduced in patients with 
CKD, and cortical oxygenation level correlated with 
CKD severity [11]. BOLD imaging was also suggested as 
a method to diagnose early kidney graft failure [12-17]. 
To our knowledge, no study has assessed the role of renal 
cortex oxygenation measurement early after transplan-
tation in the prediction of delayed renal graft function. 
Therefore, we aimed to assess the feasibility of BOLD im-
aging in the early period after kidney transplantation in 
order to establish R2*measurement variability and to ver-
ify the value of R2* in predicting delayed graft function.
Material and methods
We performed renal BOLD examinations in 40 kidney 
graft recipients (patients) and 10 healthy controls. Patients 
were included if their clinical state enabled MRI examina-
tion within the first week after transplantation. Controls 
with no history of kidney disease were included if their 
eGFR was ≥ 90 ml/min/1.73 m2. Exclusion criteria were as 
follows: claustrophobia, metallic implants, dyspnoea, and 
peritoneal dialysis. Informed consent was obtained from 
all participants. The study was approved by our University 
Review Board.
MRI examinations were performed with a 1.5-T scan-
ner (GE Optima 450wGEM, General Electric Healthcare, 
Waukesha, USA). In patients, the examinations were per-
formed within one week after surgery. Breath-hold, axial, 
T2WI, multi-gradient-recalled-echo sequences were ac-
quired (TR, 56.4 ms; TE, 1.2-20.6 ms; flip angle, 25°; slice 
thickness, 8 mm; matrix, 128 × 128). The R2*-parametric 
maps were generated with a two-parameter fitting algorithm 
and a confidence level of 0.01. The R2* values were averaged 
across three ROIs of 10 mm in diameter. ROIs were placed 
on the largest cross-section of the kidney and were located 
peripherally within the renal parenchyma in the anterior, 
middle, and posterior part of the graft (Figure 1). 
Measurements in transplant patients were correlated 
with basic laboratory parameters in the early period after 
transplantation, including eGFR, serum creatinine con-
centration (SCr), proteinuria, serum uric acid and glucose 
concentration, white blood cell count (WBC), red blood 
cell count (RBC), and haematocrit (HCT). The R2* val-
ues were also correlated with eGFR and SCr at long-term 
follow-up. To establish inter-reader reproducibility of 
measurements, R2* was measured on parametric maps in 
three cortical regions of interest (ROIs) by two observers, 
both with five years of experience in abdominal MRI. For 
intra-reader reproducibility calculation both observers re-
peated their measurements after six months. Images were 
anonymised before analysis. 
Data were presented as means with 95% confidence 
intervals (95% CI). Intra-reader variability and inter- 
reader variability were assessed with the coefficient of 
variation (CV) and the intraclass correlation coefficient 
(ICC). The results from both observers were also tested 
for differences with repeated measures ANOVA. Stand-
ard error of measurement (SEM) was a measure of ab-
solute agreement: SEM = SD (standard deviation) × root 
(1-ICC). Finally, the minimal detectable change (MDC) 
was calculated as the smallest change in R2* value that 
could be interpreted as a real difference [18]: MDC = 1.96 
× square root of 2 × SEM. Differences in oxygenation es-
timates between patients and controls were tested with 
the independent samples t-test. The relationship between 
R2* values, graft function, and laboratory parameters was 
analysed with multiple regression and logistic regression. 
P < 0.05 was considered significant. 
Figure 1. Example of ROIs placement in a transplanted kidney on axial R2* 
map
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Results
The clinical characteristics of patients are presented in Ta-
ble 1. We rejected examinations of seven patients (18%) 
due to subjective poor image quality that was related to 
motion artefacts. Repeated measures ANOVA did not 
show significant differences between the three ROI val-
ues in either of the observers. In a per-ROI analysis, the 
mean intra-reader CV was 6% for observer A and 9% for 
observer B, respectively. The intraclass correlation coeffi-
cient was 0.79 and 0.87 for observer A and observer B, re-
spectively. In a per-patient analysis, the mean inter-reader 
CV was 11%, with a wide range of 0% to 66%. The overall 
inter-reader CV was 14.6%, SEM was 0.10 Hz, and MDC 
was 0.28 Hz. 
The mean cortical R2* value was 11.6 Hz (95% 
CI: 11.2 to 12.0) in transplant recipients and 15.9 Hz 
(95% CI: 14.4 to 17.3) in controls (p = 0.0001, Figure 2). 
On multiple regression analysis, we did not observe any 
significant relationship between the R2* values and the 
studied clinical parameters. However, patients with eGFR 
≥ 40 ml/min/1.73 m2 had higher R2* values than those 
with eGFR < 40 ml/min/1.73 m2 (12.0 Hz vs. 11.1 Hz, 
respectively; p = 0.0189; Figure 3). On ROC analysis, R2* 
values ≤ 11.7 predicted impaired graft function defined as 
eGFR < 40 ml/min/1.73 m2; sensitivity of 82%, specificity 
of 56%, area under the curve (AUC) = 0.708 (p = 0.024; 
Figure 4). 
The mean follow-up duration was 31.3 months (range: 
26-45 months). Two patients were lost to follow-up. On 
the last measurements, the mean SCr was 1.39 (95% 
CI: 1.20 to 1.58), and the mean eGFR was 53.1 (95% CI: 
46.3 to 59.8). At the long-term follow-up, R2* was not 
a significant predictor of kidney function, and there was 
no significant difference in post-transplant R2* values 
between patients with eGFR ≥ 40 ml/min/1.73 m2 and 
those with eGFR < 40 ml/min/1.73 m2 (11.6 vs. 11.9, 
respectively). Multiple regression analysis of R2* values 
Table 1. Clinical characteristics of patients
Parameter Mean value (95% CI) Range
Age (years) 51.8 (46.1-57.5) 18-81
SCr (mg/dl) 2.81 (1.95-3.68) 0.47-9.86
eGFR (ml/min/1.73 m2) 42.5 (31.3-53.6) 4.8-149.1
Proteinuria (g/24 h) 0.55 (0.37-0.73) 0.00-1.00
Uric acid (mg/dl) 4.10 (3.39-4.81) 2.10-9.20
Glucose (mg/dl) 96.4 (79.9-112.8) 69.0-318.0
WBC (109/l) 8.06 (7.05-9.07) 3.89-16.1
RBC (109/l) 3.42 (3.25-3.60) 2.69-5.43
HCT (%) 31.1 (29.7-32.6) 25.6-47.2
Figure 2. Comparison of cortical R2* values in transplant recipients and 
controls. Mean values and 95% CIs are given
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Figure 3. Comparison of cortical R2* values between patients with eGFR 
< 40 ml/min/1.73 m2 and those with eGFR ≥ 40 ml/min/1.73 m2
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Figure 4. A ROC curve presents R2* values as a predictor of an early im-
paired graft function defined as eGFR < 40 ml/min/1.73 m2
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and laboratory parameters did not allow the generation 
of any model to predict either early or delayed graft 
function.
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Discussion
To our knowledge, we showed for the first time that 
BOLD imaging performed early after transplantation has 
a limited value in predicting delayed renal graft function. 
We found that R2* values were moderately related to early 
graft function. Finally, based on inter-reader reproduci-
bility analysis, the minimal detectable change in R2* was 
only 0.28 Hz. 
In our study, 18% of patients were excluded from the 
analysis due to inadequate image quality. Similar rejection 
rates were reported by Sadowski et al. [14] and Niles et al. 
[19] but not by other researchers [15,16,20,21]. We suspect 
that this could have been due to the short time between re-
nal transplantation and scanning. Breathing motions were 
the main source of image artefacts because, due to pain 
and common overhydration, patients in the early period 
after renal transplantation have a limited ability to hold 
their breath and to lie still in a supine position throughout 
the entire MRI examination. Thus, neither respiratory-gat-
ed nor breath-hold techniques guarantee images free from 
movement artefacts in this group of patients. However, we 
preferred breath-hold sequences because of shorter total 
examination times. Xiao et al. observed a loss of signal in 
the marginal area of the transplanted kidney [21] because 
the bowel gas surrounding the kidney caused inhomoge-
neity in local magnetic fields and susceptibility artefacts. 
We did not notice this problem in our group. 
To our knowledge, renal R2* measurement variability 
has not been studied. In the current study, the intra-read-
er CV ranged between 6% and 9%, and the inter-reader 
variability was 14.6%. In a per-patient analysis, the mean 
inter-reader presented a wide range of values (0% to 66%), 
which may be explained by the fact that ROI placement 
was left to the discretion of observers. The calculat-
ed MDC indicated that a difference of 0.28 Hz may be 
considered significant for different observers or different 
ROI placement methods. However, it does not take into 
account the physiological differences that may introduce 
some variability to repeated scanning. Recently, two stud-
ies have assessed the reproducibility of repeated BOLD 
examinations. In four patients, Park et al. reported that 
the mean difference in cortical or medullary R2* values 
between two MRI examinations at a one-month inter-
val was 0.6-3.8%, depending on the sequence used [20]. 
However, that study lacked statistical power due to a small 
sample. Thoeny et al., who studied only seven subjects, re-
ported an inter-scan cortical R2* variability of 4.0% [22]. 
Several authors have previously tested the relationship 
between R2* values and graft function. Vermathen et al. 
did not observe any relationship between eGFR and ox-
ygenation estimates in repeated examinations performed 
7 ±3 months after transplantation and 32 ±2 months after 
initial MRI [17]. Similar results were reported by Seif et al. 
[23]. In the study by Xiao et al., Scr levels were negatively 
correlated with R2* values; however, that correlation was 
weak (Spearman coefficient of −0.29) [21]. In our study, 
there was no relationship between cortical R2* values and 
clinical parameters, including eGFR, SCr, and proteinuria. 
However, we observed a difference in renal cortical oxy-
genation between patients with eGFR ≥ 40 ml/min/1.73 m2 
and those with eGFR < 40 ml/min/1.73 m2, which may in-
dicate decreased graft function. Using this eGFR threshold, 
R2* values ≤ 11.7 predicted impaired kidney function with 
good sensitivity (82%) and poor specificity (56%). Thus, the 
test may be considered to rule out the graft failure but not 
to confirm it. Based on previous studies and our data, we 
can suppose that renal cortical R2*values are not strongly 
related to the common parameters of renal early graft func-
tion, including eGFR. Moreover, the role of this method 
in predicting delayed graft function is limited. We found 
no relationship between the R2* values measured within 
a week after transplantation and follow-up eGFR, even if 
the threshold of 40 ml/min/1.73 m2 was used. 
Our study had some limitations. First, we included 
a small number of participants, but our sample size was 
comparable to previous studies on renal graft oxygenation. 
What is more, only two patients were lost for follow-up. 
However, the role of early R2* measurement for graft func-
tion prediction should be assessed in a larger study. Since 
the mean follow-up duration was over 2.5 years, several 
factors other than the initial post-transplant renal cortex 
oxygenation might have influenced the final outcome. To 
account for such confounders, a larger study will have to 
be performed. Second, we only measured cortical oxygen-
ation, which was in line with previous studies, such as the 
significant work by Milani et al. [11]. Finally, averaging 
over three ROIs might have led to some measurement er-
rors, and averaging over whole cross-sections or even over 
whole cortical volumes could have been better [11,19]. 
However, such methods are still experimental and require 
validation before clinical application. 
Conclusions
In conclusion, BOLD MRI-based evaluation of renal graft 
oxygenation early after transplantation is technically chal-
lenging. In practice, an R2* value of 0.28 Hz can be con-
sidered as the minimal detectable change. Despite the fact 
that R2* values are related to eGFR, BOLD has limited 
potential to predict early graft function. Delayed graft 
function does not seem to be dependent on early renal 
cortical oxygenation. 
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